TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials.

Evguenia S Svarovskaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.